Schonfeld Strategic Advisors’s GeneDx Holdings WGS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.06M	Buy	32,105 +14,767	+85%	+$1.35M	0.01%	810
2025 Q4	$2.25M	Buy	17,338 +4,311	+33%	+$592K	0.01%	832
2025 Q3	$1.4M	Sell	13,027 -159,356	-92%	-$17.4M	0.01%	1214
2025 Q2	$15.9M	Buy	+172,383	New	+$13.5M	0.11%	220
2022 Q1	–	Sell	-7,116	Closed	-$1.05M	–	2953
2021 Q4	$1.05M	Buy	7,116 +3,277	+85%	+$732K	0.01%	918
2021 Q3	$962K	Buy	+3,839	New	+$1.32M	0.01%	976
2021 Q2	–	Sell	-4,130	Closed	-$2.03M	–	2351
2021 Q1	$2.03M	Buy	+4,130	New	+$2.15M	0.02%	653

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Schonfeld Strategic Advisors's WGS Position: Q1 2026 in Review

Schonfeld Strategic Advisors increased its GeneDx Holdings (WGS) stake by 85% in Q1 2026, buying an estimated $1.35M and bringing the position to 32,105 shares worth $2.06M. The position accounts for 0.01% of the portfolio, ranked #810.

Schonfeld Strategic Advisors first reported a position in WGS in Q1 2021 and has held it in 7 quarters since. The position peaked at $15.9M in Q2 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

Schonfeld Strategic Advisors held 32,105 shares of GeneDx Holdings worth $2.06M as of Q1 2026.
Schonfeld Strategic Advisors bought 14,767 GeneDx Holdings shares in Q1 2026, an estimated $1.35M.
GeneDx Holdings made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #810 holding.
Schonfeld Strategic Advisors first reported a position in GeneDx Holdings in Q1 2021 and has held it in 7 quarters since.
Schonfeld Strategic Advisors's GeneDx Holdings position peaked at $15.9M in Q2 2025.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.